ARTICLE | Clinical News
Arimidex anastrozole aromatase inhibitor regulatory update
January 22, 2002 8:00 AM UTC
The FDA granted Fast Track designation for AZN's Arimidex's supplementary NDA to treat post-menopausal women with early-stage breast cancer. Arimidex is approved in the U.S. as a first-line therapy fo...